Articles About The Tech Sector

You Can Cover Virtually Every High-Tech Breakthrough On The Market With Just This One Investment

0 | By Michael A. Robinson

Pandemic or not, I’m doing my part to keep the chip industry healthy.

See, I just bought three dozen semiconductors.

And I don’t meant shares in chip companies.

To be more energy-efficient, I bought a bunch of semiconductors disguised as lightbulbs.

Let me explain: I bought LEDs, or Light Emitting Diodes. These are tiny semiconductors that emit light when electrical current flows through them.

They’re used in TV remotes, monitors, smartphones, and of course, lightbulbs. They use a fraction of the juice that conventional lightbulbs do.

Grand View Research say the global LED lighting market alone is set to grow by 13.4% annually from $54 billion last year until it reaches $127 billion in 2027.

As impressive as that sounds, that’s still just a small part of the $430 billion chip sector.

And today I want to show you why the industry is doing well at a tough time and reveal a market-beating way to play this vital industry…

One In Five Americans Could Need This Company’s Services By 2030 – And They Can Claim You A Piece Of $225 Billion

1 | By Michael A. Robinson

The easiest class I took in college more than 40 years ago is turning out to be very valuable these days.

It was a sociology course on aging that I rarely attended. But I did read the textbook carefully,

And I’m glad I did. It helped prepare for recent events involving my in-laws and my dad.

We recently had to move my aging in-laws into an assisted living facility. Meanwhile my dad, age 87, wants to remain at home but needs regular care.

I’m bringing this all up because it’s part of a huge national trend. By 2030, 20% of the population will be seniors, nearly double the figure in 2009.

By 2024, this demographic will push the home healthcare market to $225 billion, up 125% from the 2016 level.

And today, I’m going to reveal a leader in this field whose stock could double in less than two years

How One of the Best Tech Stocks to Buy Today Is Tapping into 300% Industry Growth

0 | By Alex Kagin

Every time I walk out of my apartment and walk past the mountain of packages left for residents in my building, I’m reminded of Inc. (NASDAQ: AMZN).

By now, everyone in the United States has heard of it. You see its packages and boxes in the recycling and delivery trucks with the large, unmistakable Amazon logo. It even has its own fleet of planes that you might see at the airport. Not just an e-commerce company, it also has a music service, the top video game streaming service, payments platform, an over-the-top entertainment platform, and one of the largest web services in the United States. This is how you create a trillion-dollar company.

According to Consumer Intelligence Research Partners, it has 112 million members in its Prime loyalty program as of December 2019. That is 34% of the U.S. population, and given that people sign up as families, eMarketer takes it one step further and suggests that 82% of households have a Prime account.

That is one truly amazing statistic.

The Race for A COVID-19 Vaccine Is Speeding Up

1 | By Alex Kagin

July 4 is one of my favorite holidays, and living in D.C., the excitement is intensified as a huge parade marches through the city and the night concludes at the National Mall with fireworks.

But this year will be very different.

Fireworks in the nation’s capital will take place in some form with many people watching from home and the National Independence Day Parade has been cancelled. The rest of the country is also still affected by COVID-19.

Eli Lilly and Johnson & Johnson Tackle COVID-19

2 | By Alex Kagin

Living in Washington, D.C., it’s good to see that COVID-19 cases, which peaked on April 30, continue to decline. As a result, restaurants, retail stores, and some barbershops have started to open in a limited capacity.

But that reopening isn’t happening everywhere.

There are still thousands of new cases daily across the United States and many states that have started to open back up such as Texas, California, and Florida continue to see a rise in new COVID-19 cases.

Five Reasons Why This Pharmaceutical Specialist Could Double Your Money in Just Two Years

0 | By Michael A. Robinson

In our twice-weekly chats, I often suggest investments that are part of large tech sectors.

For instance, the life sciences field defines huge. Just the prescription drug segment alone will be worth $1.2 trillion by 2024, according to data from Statista.

So, you might be wondering why I am focused on a medical area that will be worth just 0.1% of that figure over roughly the same time frame.

It’s a fair question. The answer is pretty basic. A high-octane leader
focused on specialty drugs can make a killing.

And the one I’m going to reveal to you today defines profit machine. It’s on pace to double per-share earnings in as little as a year.

With that in mind, let me show you five reasons why this wealth-building biotech firm should at the very least be on your radar screen….

This Stock Crushed the Broader Market – And Now It’s Helping Exhausted Healthcare Workers

0 | By Michael A. Robinson

I want to start today’s chat with a tech-investing challenge.

How many of you can claim you have a stock in your portfolio that is up nearly 230% in just 16 months?

As impressive as that return sounds, it actually understates the strength of the stock I have in mind. It’s a medical device leader that recently received approval for a Covid-19 test.

It’s up 120 in the past two months alone…

But this is no flash in the pan. Even before that breakthrough occurred, the stock was a bona fide market crusher

From roughly the beginning of 2019 through the correction that began on February 19, the stock was ahead of the S&P 500 by an amazing 278.5%.

The firm I have in mind is leading the medical device market as part of a trend toward remote patient monitory.

With the coronavirus still fresh on everyone’s minds, the investment thesis is only getting better.

So, today I’m going to reveal why the stock could double in as little as three years and show you how to get in on the action

Not Even the Coronavirus Can Stop Amazon – Here’s How You Can Take Advantage

0 | By Michael A. Robinson

Not even a brutal market selloff can keep Inc. (AMZN) down.

Here’s the thing. This is no ordinary bear market, one defined as a 20% drop from the previous high.

It’s the coronavirus panic that has most of the economy in a deep freeze.

As a result, physical retail stores are getting hammered. The U.S. Commerce Department says retail sales for March fell a seasonally adjusted 8.7%.

That’s the biggest one-month decline since the agency began keeping records back in 1992.

And while Amazon definitely faced some supply chain issues, the King of E-commerce came through when the nation needed the tech giant’s help the most. It delivered millions of packages to homebound families all across America.

With that performance under its belt, yesterday the firm’s stock hit a record high – a feat that few stocks can match.

With that in mind, today I’m going to show you why my target price of $3,000 a share looks very conservative…

The Coronavirus Can’t Break a Strong Tech Foundation

0 | By Strategic Tech Investor Staff

The coronavirus crisis is an event like nothing we’ve seen before in our lifetimes. It’s put an unprecedented strain on our economy by forcing people to stay in their homes. The markets may be down, but many of the same high-tech innovations that drove the pre-virus economy to new heights are helping society stay connected now. That means working from home, shopping for necessities online, and keeping in touch with friends and family. In short, online infrastructure has gone from convenient to totally indispensable. This is a prime opportunity for any online innovator to rise to the occasion, and rise in value. And when this crisis passes, tech will be poised to lead the market again. Click here to watch.

The High-Tech Outlook for the Coronavirus Crisis: Part 2

1 | By Michael A. Robinson

When we spoke on Tuesday, I made a bold prediction: the Covid-19 outbreak, while serious, will not be as bad as the worst-case predictions would have it.

For one, much of the country is already on lock-down, cutting off the spread of the disease. That is buying us some valuable time as researchers race to find a cure or at least a good treatment option.

And I’m happy to report there have been some exciting developments in the search for treatments and vaccines against Covid-19

Last week, I noted that most vaccine research remains rooted in 1950s technology.

Despite mapping the entire human genome back in April 2004, drug firms and scientists still rely on slowly growing viruses inside chicken eggs to create a vaccine.

This takes a lot of time – and a lot of eggs.

But the Covid-19 pandemic has them racing to find a treatment using novel and fascinating science.

With that in mind, today I want to take a closer look at some of the promising 21st Century research pushing the boundaries of this field